Rehmann Capital Advisory Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.08K | Sell |
508
-19
| -4% | -$40 | ﹤0.01% | 1543 |
|
|
2019
Q2 | $1.41K | Hold |
527
| – | – | ﹤0.01% | 1856 |
|
|
2019
Q1 | $2.59K | Buy |
527
+165
| +46% | +$812 | ﹤0.01% | 1690 |
|
|
2018
Q4 | $1.07K | Buy |
362
+315
| +670% | +$934 | ﹤0.01% | 1632 |
|
|
2018
Q3 | $319 | Sell |
47
-286
| -86% | -$1.94K | ﹤0.01% | 2083 |
|
|
2018
Q2 | $2.51K | Buy |
333
+265
| +390% | +$2K | ﹤0.01% | 1737 |
|
|
2018
Q1 | $2K | Buy |
+68
| New | +$2K | ﹤0.01% | 1709 |
|